Hayleigh Collins | executive |
Sean Nolan | executive |
Sukumar Nagendran | executive |
Kamran Alam | executive |
Kristen Kluska | analyst |
Salveen Richter | analyst |
Whitney Ijem | analyst |
Joon Lee | analyst |
Maurice Raycroft | analyst |
Christopher Raymond | analyst |
Gil Blum | analyst |
Yanan Zhu | analyst |
Jack Allen | analyst |
Silvan Tuerkcan | analyst |
Greetings, and welcome to the Taysha Gene Therapies First Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Hayleigh Collins. Thank you.
You may begin.